ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1400	National Cancer Institute	Html	en	Pruritus (PDQ®)–Patient Version	Expert-reviewed information summary about pruritus (itching of the skin) as a complication of cancer or its treatment. Approaches to the management and treatment of pruritus are discussed.	pruritus 0.90328 cancer treatment 0.548786 pruritus triggers 0.621529 itchy area 0.539512 PDQ cancer information 0.801119 sensitive skin 0.546664 clinical trials 0.578 slightly warm water 0.581894 skin irritation 0.524209 cancer information summary 0.687111 clinical trial 0.527617 breast cancer prevention 0.527738 allergic skin reactions 0.565555 PDQ summaries 0.536776 NCI’s PDQ 0.543089 NCI PDQ cancer 0.611108 abnormally dry skin 0.57148 radiation therapy 0.699633 mild skin cleansers 0.572586 healthy skin 0.527165 dry skin 0.774485 severe pruritus 0.605619 treatment 0.566915 skin reactions 0.571172	cancer prevention 0.529379 skin 0.938312 fabric softener 0.603284 Cancer Information Service 0.550768 PDQ Supportive 0.525373 Skin care 0.536556 treatment clinical trials 0.52545 National Cancer Institute 0.683212 PDQ documents 0.525692 pruritus feels 0.65464 Palliative Care Editorial 0.58903 new treatment 0.528187 Long-term dry skin 0.58669 Cancer Care page 0.536284 PDQ database 0.530553 Care Editorial Board 0.591687 skin stay 0.527676 PDQ summary 0.56881 skin biopsy 0.53042 sedimentation rate 0.58564 skin cells 0.531813 skin lesions 0.545694 cancer information summaries 0.561413 comprehensive cancer information 0.556845	CLICK HERE
1410	National Cancer Institute	Html	en	Endometrial Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing endometrial cancer and about research aimed at the prevention of this disease.	Surgical Adjuvant Breast 0.47836 Obstet Gynecol 0.483376 World Cancer Research 0.452806 endometrial carcinoma 0.52954 Engl J Med 0.456388 American Cancer Society 0.497798 Br J Cancer 0.455416 case-control study 0.441437 Int J Cancer 0.478131 early-stage breast cancer 0.461817 intentional weight loss 0.529248 breast cancer treatment 0.473891 breast cancer patients 0.472714 body mass index 0.470175 endometrial cases 0.529694 Cancer Causes Control 0.452081 Natl Cancer Inst 0.529481 lower endometrial cancer 0.563354 postmenopausal endometrial cancer 0.554715 modifiable risk factor 0.44186 endometrial cancer 0.948645 invasive breast cancer 0.472622 Cancer Treat Rep 0.454232 et al. 0.498732	early breast cancer 0.472532 tamoxifen-treated breast cancer 0.462067 nonpolyposis colorectal cancer 0.457467 endometrial cancer cases 0.601622 polycystic ovarian syndrome 0.445837 Cancer Epidemiol Biomarkers 0.47249 endometrial cancer risk 0.82277 Cancer Facts 0.44862 PUBMED Abstract 0.515106 Nutr Cancer 0.444116 widespread endometrial cancer 0.555715 Epidemiol Biomarkers Prev 0.442397 endometrial cancer incidence 0.612962 Breast Cancer Prevention 0.475561 African American women 0.440785 invasive gynecologic cancer 0.464853 postmenopausal women 0.497969 Abstract 0.52778 breast cancer 0.526041 adjuvant tamoxifen 0.441172 physical activity 0.445711 Breast Cancer Study 0.467445 breast cancer incidence 0.479289 National Surgical Adjuvant 0.475167	CLICK HERE
1513	National Cancer Institute	Html	en	Pancreatic Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of pancreatic cancer.	pancreatic carcinoma E6201 0.398831 unresectable pancreatic carcinoma 0.359985 pancreatic malignancy 0.311753 Engl J Med 0.337007 Ann Surg 0.317423 German CONKO-study group 0.318318 phase iii trial 0.413157 pancreatic tumors 0.328586 der Schelling GP 0.325496 randomized phase 0.350612 advanced pancreatic adenocarcinoma 0.470438 randomized trial 0.376847 patients 0.470655 investigational new drug 0.321651 Cooperative Oncology Group 0.454021 van der Schelling 0.325555 Moore MJ 0.343635 fixed-dose rate infusion 0.313379 pancreatic carcinoma 0.542646 Ann Oncol 0.304631 et al. 0.690156 Best supportive care 0.315629 study 0.356854 Expandable metal stents 0.329142	phase ii trial 0.320548 Hammel et al. 0.336299 Oncology Group study 0.328761 Clinical Trials Group 0.319844 gemcitabine-based induction chemotherapy 0.328647 National Cancer Institute 0.337583 den Bosch RP 0.325608 advanced unresectable pancreatic 0.366836 metastatic pancreatic cancer 0.353118 advanced pancreatic cancer 0.926655 advanced pancreatic carcinoma 0.404683 unresectable periampullary adenocarcinoma 0.332936 first-line therapy 0.306838 van den Bosch 0.324595 refractory pancreatic cancer 0.407704 advanced pancreas cancer 0.35576 Abstract 0.559395 Clin Oncol 0.91428 unresectable pancreatic cancer 0.410252 Canada Clinical Trials 0.318756 Eastern Cooperative Oncology 0.46104 drug treatment program 0.320206 gemcitabine 0.380059 active chemotherapy regimens 0.332336	CLICK HERE
1573	National Cancer Institute	Html	en	Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of paranasal sinus and nasal cavity cancer.	clinical trial 0.388177 treatment 0.382326 nasal cavity cancer 0.775733 nasal cavity 0.985485	radiation therapy 0.64284 cancer 0.858763 paranasal sinus 0.474859 clinical trials 0.346263	CLICK HERE
1739	National Cancer Institute	Html	en	Paget Disease of the Breast	A fact sheet about Paget disease of the breast, a rare type of cancer that is sometimes called Paget disease of the nipple or mammary Paget disease.	widely accepted theory 0.431005 Paget disease 0.968679 lymph node dissection 0.448538 breast travel 0.50595 Female Breast 0.492116 benign skin conditions 0.467839 invasive cancer 0.46682 Breast Cancer Research 0.515399 nearby lymph nodes 0.47834 5-year relative survival 0.483297 circular cutting tool 0.430646 lymph node biopsy 0.495901 sentinel lymph node 0.515084 areola 0.440286 entire nipple 0.437315 additional diagnostic tests 0.431017 Paget cells 0.564932 breast tumor 0.509157 lymph nodes 0.480504 nipple biopsy 0.469807 lymph node surgery 0.448775 invasive breast cancer 0.541802 breast lump 0.501651 extramammary Paget disease 0.567848 magnetic resonance imaging 0.430693	cancer cells 0.444445 breast cancer recurrence 0.516664 benign skin condition 0.434676 National Cancer Institute 0.437477 tumor cells 0.436713 early symptoms 0.436544 rare type 0.434028 breast changes 0.501251 breast tumors 0.519719 British doctor Sir 0.43376 Breast Journal 0.497022 clinical breast exam 0.531889 breast cancer 0.589051 HER2 protein overexpression 0.430335 Sir James Paget 0.592188 people 0.452202 breast cancer treatments 0.51665 lymph node involvement 0.446932 darker circle 0.435564 axillary lymph node 0.477668 mammary Paget disease 0.579396 et al 0.471939 breast 0.816594 Surgical Oncology 0.430364	CLICK HERE
1920	National Cancer Institute	Html	es	Tratamiento del cáncer de vejiga (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vejiga.	pequeño bucle 0.447801 siguientes procedimientos 0.673413 Schistosoma haematobium 0.482783 cistectomía segmentaria 0.460288 estadio iv 0.822603 cáncer.ampliar cistoscopia 0.483661 pequeña cantidad 0.462732 estadio ii 0.569624 túbulos renales 0.485429 siguientes tipos 0.465952 rayos x 0.462117 sistema urinario masculino 0.534793 enlace drugs approved 0.625136 células t 0.506117 posibles signos 0.638701 National Cancer Institute 0.427365	pelvis renal 0.667965 Instituto Nacional 0.454933 PDQ Tratamiento 0.458142 antecedentes familiares 0.468632 Physician Data Query 0.515351 Bladder Cancer 0.523198 estadio iii 0.506874 siguientes situaciones 0.472048 vejiga almacena 0.929353 pequeños hongos 0.45501 panel derecho 0.577787 células renales 0.591906 siguientes sumarios 0.537471 siguientes pruebas 0.493409 siguientes estadios 0.478175	CLICK HERE
2005	National Cancer Institute	Html	es	Tratamiento de los tumores de estroma gastrointestinal (PDQ®)–Versión para pacientes	Información revisada por expertos sobre el tratamiento de los tumores de estroma gastrointestinal.	pequeñas incisiones 0.627953 siguientes procedimientos 0.660138 cuidado médico 0.818499 tubo gi.ampliar 0.664881 siguientes aspectos 0.645973 Neurofibromatosis tipo 0.638907 siguientes síndromes 0.651683 rayos x 0.707199 enlace drugs approved 0.645052 escáner tep 0.637347 ondas sonoras 0.640024 National Cancer Institute 0.620652 causarán signos 0.637878	siguientes riesgos 0.61572 Instituto Nacional 0.681879 PDQ Tratamiento 0.652674 siguientes problemas 0.648983 tubo gi 0.979564 Physician Data Query 0.683259 tumor mide 0.671706 PDQ Cánceres 0.69873 siguientes enlaces 0.62151 siguientes órganos 0.656962 siguientes pruebas 0.650191 Gastrointestinal Stromal Tumors 0.704979	CLICK HERE
3670	National Cancer Institute	Html	es	Estudio TAILORx indica que mujeres con riesgo bajo de recurrencia de cáncer de seno pueden abstenerse de quimioterapia	Resumen de resultados del estudio TAILORx indica que mujeres con cáncer de seno receptor de hormonas en estadio inicial tienen un riesgo bajo de recurrencia según una prueba de expresión de 21 genes.	Assigning Individualized Options 0.731016 NIC-Clinical Trials Group 0.677172 Therapy Evaluation Program 0.674291 quimioterapia adyuvante mejora 0.979078 doctor joseph sparano 0.667749 doctora jo anne 0.660047 llamada puntuación 0.615517 Estados Unidos 0.857653 NRG Oncology 0.56481	excelentes resultados 0.548811 cuáles mujeres 0.873744 Oncotype DX® 0.57646 invasivo enfermedad 0.55814 New England Journal 0.693093 Clinical Oncology 0.572538 Nueva Zelanda 0.530968 estudio tailorx 0.733998	CLICK HERE
3769	National Cancer Institute	Html	es	Medicina de precisión en el tratamiento del cáncer	Información sobre el papel que tiene la medicina de precisión en el tratamiento del cáncer.	precisión para tratamiento 0.796037 máquina llamada secuenciador 0.682468 cuáles cambios 0.881741 cuáles tratamientos funcionarán 0.880419 que los pacientes 0.633734	campo de investigación 0.604701 seguro médico 0.550546 cáncer el cambio 0.9829 responda el tumor 0.621072 a cuáles tratamientos 0.724195	CLICK HERE
16838	National Cancer Institute	Html	en	University of Texas — Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology	The focus of the University of Texas MD Anderson Cancer Nanotechnology Training Center is presented here.	unique boot camp 0.665183 lab management skills 0.648892 Rice University 0.515834 M.D. 0.338543 Objectives 0.334693 MD Anderson 0.892403 preparation 0.332958 independent careers 0.500052 problem 0.335383 MD Anderson CNTC 0.66004 Ph.D. 0.338612 seminar experiences 0.507875 translational research 0.966631 academic labs 0.516268 hands-on coursework 0.547621 project management 0.489839 Konstantin Sokolov 0.587384 future leaders 0.517794 independent research project 0.702082 Texas 0.33468 cancer nanotechnology 0.891595 translational research projects 0.795763 training program 0.532137 multidisciplinary mentorship 0.538033 post-doctoral training 0.533942	trainees 0.545607 specific interests 0.517161 Rebecca 0.339233 research fellowship grant 0.692269 multidisciplinary field 0.50801 Ph.D 0.333304 cancer translational research 0.824834 Cancer Management 0.515303 gap 0.336671 Principal Investigator 0.540969 Didactic coursework 0.550767 completion 0.335106 Center 0.334629 MD Anderson Cancer 0.714625 NCI Nanotechnology Characterization 0.789772 program faculty mentors 0.704052 current opportunities 0.49661 federal resources 0.494134 new discoveries 0.52212 Sunil Krishnan 0.581597 deep understanding 0.497785 barriers 0.38628 introductory course 0.486248 Training Focus 0.539936	CLICK HERE